Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
English Section

EU approves J&J's single-dose COVID-19 vaccine

12.03.2021 07:20
The European Union has approved Johnson & Johnson's single-dose COVID-19 vaccine, raising hopes for stepped-up inoculation in Poland and across the 27-nation bloc.
Johnson  Johnsons Janssen COVID-19 vaccine.
Johnson & Johnson's Janssen COVID-19 vaccine.Photo: EPA/TIMOTHY D. EASLEY

The shot developed by the US drug maker is the first single-dose COVID-19 vaccine and the fourth to be endorsed for use in the EU after those from Pfizer-BioNTechModerna and AstraZeneca-Oxford University.

The Johnson & Johnson vaccine has been found to be 67 percent effective two weeks after inoculation and is recommended for people aged over 18, the European Medicines Agency said on Thursday.

The United States, Canada and Bahrain have also approved the shot, while South Africa is carrying out an expedited review, the Reuters news agency reported.

"With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens," the European Medicines Agency's Executive Director Emer Cooke was quoted as saying after the drug regulator gave its conditional approval.

The European Commission officially greenlighted the vaccine later in the day, paving the way to its use across the bloc as countries struggle to contain a more contagious variant of the coronavirus.

EU executive chief Ursula von der Leyen tweeted that "more safe and effective vaccines" were coming to the market.

"With the number of doses we ordered, we could vaccinate up to 200 million people in the EU," she said.

The first shipments of the J&J vaccine are expected in the second half of April, with the company initially promising to deliver at least 200 million doses to the EU this year.

Poland's Health Minister Adam Niedzielski told a news conference last week that his country had ordered 16 million doses of the Johnson & Johnson shot and that the first shipments were expected to arrive next month.

Michał Dworczyk, the official overseeing Poland’s inoculation drive, said on Wednesday that the government had secured assurances from vaccine manufacturers that around 15 million COVID-19 vaccine doses would be delivered to the country in the second quarter of this year.

This will include 2.5 million single-dose Johnson & Johnson shots, Dworczyk told a news conference.


Source: IAR, PAP, Reuters